[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@EliKorey Avatar @EliKorey Eli Korey

Eli Korey posts on X about $ntla, at least, $prme, $beam the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XX% cryptocurrencies XXXXX% finance XXXX% social networks XXXX% technology brands XXXX%

Social topic influence $ntla #6, at least 13.33%, $prme #13, $beam #15, $regn #21, to the 13.33%, arb 6.67%, $arwrs 6.67%, $wve 6.67%, $pfe XXXX%

Top accounts mentioned or mentioned by @3primeanalytica @michaelmaiello @zhaoweiasu @geneinvesting @bicepcrypto @markc_lvb

Top assets mentioned Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) Regeneron Pharmaceuticals Inc (REGN) Wave Life Sciences Ltd. Ordinary Shares (WVE) Pfizer, Inc. (PFE) Novo-Nordisk (NVO)

Top Social Posts

Top posts by engagements in the last XX hours

"@zhaoweiasu It may be a knock off of prime editing but Tessera will be in the clinic at least X months prior to $PRME assuming Prime wins their arb battle with $BEAM. Maybe $regn believes it can not only box out $prme but offer a superior solution to $beam"
X Link 2025-12-01T19:46Z XXX followers, XXX engagements

"@3primeAnalytica @GeneInvesting Exactly. $prme will be at least X years behind $beam and at least X months behind Tessera/$regn. They could be in a box and needing the courts to help them in ultimately competing in this ever growing crowded indication"
X Link 2025-12-01T20:57Z XXX followers, XXX engagements

"If $ARWR's upcoming INHBE data in January confirms what we just saw reported by $WVE I wonder how quickly big pharma might move in. We all know that $PFE and $NVO are a bit desperate"
X Link 2025-12-08T13:22Z XXX followers, XXX engagements

"No one should be surprised that the shorts are pressing their bets on $NTLA. The only near term catalyst will be the removal of a negative clinical hold. And while this removal will cause a pop in the stock price it is unlikely to cause the stock to go back into the 20's in the"
X Link 2025-12-10T14:33Z XXX followers, XXX engagements

"@MichaelMaiello @Bicep_crypto If the FDA did deliver the clinical hold letter on the 30th day following initial communication of such action then $NTLA has until the end of today to file an 8k"
X Link 2025-12-04T14:59Z XXX followers, XXX engagements

"If we do not see an 8k from $NTLA by the end of today The FDA will have missed their XX day requirement. Then the obvious question will be. how much of a delay will occur Did the govt shutdown cause the delay or simply the chaos with this current FDA"
X Link 2025-12-05T14:56Z XXX followers, XXX engagements

"The warm reception many biotech companies are receiving on capital raises is a far cry from the last few years. This brings me to $NTLA granted the unfortunate SAE killed any chance of them raising funds following the outstanding data on ATTR and HAE but let's be honest"
X Link 2025-12-09T14:57Z XXX followers, XXX engagements

"$NTLA pounded the ATM in q3 prior to the SAE and data release at an average price just over $XX. Still head scratching to me. I am expecting that in the first few weeks of q4 prior to the SAE NTLA hit the ATM again with the pps north of $XX. If the company chose not to hit the"
X Link 2025-12-09T14:57Z XXX followers, XXX engagements

"ATM in that time period at a pps double what they sold in q3 I will really question the decision making of the BOD including the CEO. I still like the prospects of $NTLA especially HAE but there are red flags popping up here and there that make me uncomfortable"
X Link 2025-12-09T14:57Z XXX followers, XXX engagements

"short term. Between yr end tax loss selling lack of catalysts & the cost of borrow being almost X short investors seem emboldened in pressing their bets. Plus the cost to hedge shorts through options is not expensive. Even at 44M $NTLA shares are still available to short"
X Link 2025-12-10T14:33Z XXX followers, XXX engagements

"No one had QE on their bingo card for this FED meeting. How soon does the market reverse to the negative as investors start looking around for scurrying cockroaches. Is Powell making a play to be renominated as Fed Chief lol. The Cheetoh is going to fire off a positive tweet"
X Link 2025-12-10T19:32Z XXX followers, XXX engagements